Showing 1 - 14 results of 14 for search 'Wood, EM', query time: 0.06s
Refine Results
-
1
How should we use convalescent plasma therapies for the management of COVID-19? by Wood, EM, Estcourt, LJ, McQuilten, ZK
Published 2020Journal article -
2
-
3
-
4
-
5
-
6
-
7
-
8
Convalescent plasma and hyperimmune immunoglobulin to prevent infection with SARS‐CoV‐2 by Valk, SJ, Piechotta, V, Kimber, C, Chai, KL, Monsef, I, Doree, C, Wood, EM, Lamikanra, AA, Roberts, DJ, McQuilten, Z, So-Osman, C, Estcourt, LJ, Skoetz, N
Published 2021Journal article -
9
Hyperimmune immunoglobulin for people with COVID-19 by Kimber, C, Valk, SJ, Chai, KL, Piechotta, V, Iannizzi, C, Monsef, I, Wood, EM, Lamikanra, AA, Roberts, DJ, McQuilten, Z, So-Osman, C, Estcourt, LJ, Skoetz, N
Published 2021Journal article -
10
Convalescent plasma or hyperimmune immunoglobulin for people with COVID‐19: a living systematic review by Piechotta, V, Iannizzi, C, Chai, KL, Valk, SJ, Kimber, C, Dorando, E, Monsef, I, Wood, EM, Lamikanra, AA, Roberts, DJ, McQuilten, Z, So-Osman, C, Estcourt, LJ, Skoetz, N
Published 2021Journal article -
11
SARS-CoV-2-neutralising monoclonal antibodies to prevent COVID-19 by Hirsch, C, Valk, SJ, Piechotta, V, Chai, KL, Estcourt, LJ, Monsef, I, Salomon, S, Tomlinson, E, Popp, M, Wood, EM, So-Osman, C, Roberts, DJ, McQuilten, Z, Skoetz, N, Kreuzberger, N
Published 2021Journal article -
12
Clinical use of convalescent plasma in the COVID-19 pandemic: a transfusion-focussed gap analysis with recommendations for future research priorities by Al-Riyami, AZ, Schäfer, R, van den Berg, K, Bloch, EM, Estcourt, LJ, Goel, R, Hindawi, S, Josephson, CD, Land, K, McQuilten, ZK, Spitalnik, SL, Wood, EM, Devine, DV, So-Osman, C
Published 2020Journal article -
13
Red cell transfusion in outpatients with myelodysplastic syndromes: a feasibility and exploratory randomised trial by Stanworth, SJ, Killick, S, McQuilten, ZK, Karakantza, M, Weinkove, R, Smethurst, H, Pankhurst, LA, Hodge, RL, Hopkins, V, Thomas, HL, Deary, AJ, Callum, J, Lin, Y, Wood, EM, Buckstein, R, Bowen, D, REDDS Investigators
Published 2020Journal article -
14
SARS‐CoV‐2‐neutralising monoclonal antibodies for treatment of COVID‐19 by Kreuzberger, N, Hirsch, C, Chai, KL, Tomlinson, E, Khosravi, Z, Popp, M, Neidhardt, M, Piechotta, V, Salomon, S, Valk, SJ, Monsef, I, Schmaderer, C, Wood, EM, So-Osman, C, Roberts, DJ, McQuilten, Z, Estcourt, LJ, Skoetz, N
Published 2021Journal article